Novateor Research Laboratories Ltd

Novateor Resear. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Novateor Research Laboratories Ltd

₹ 29.0 -7.88%
05 Sep - close price
novateor.com BSE - SME: 542771
About

Incorporated in 2011, Novateor Research Laboratories Ltd develops personal care products[1]

Key Points

Business Overview:[1]
Company manufactures Teeth Whitening products which are sold under brand name SmiloShine. It manufactures ~3 variants of Strips, Toothpaste and tongue cleaner which are approved by FDCA. Company intends to expand its business in cosmetics and healthcare products. Company’s customer base consists of Dentists and Cosmetic Parlors

Website BSE
  • Market Cap ₹ 17.6 Cr.
  • Current Price ₹ 29.0
  • High / Low ₹ 57.5 / 28.3
  • Stock P/E 219
  • Book Value ₹ 21.8
  • Dividend Yield 0.00 %
  • ROCE 1.70 %
  • ROE 0.83 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding has decreased over last quarter: -9.27%
  • Company has a low return on equity of 0.58% over last 3 years.
  • Company has high debtors of 272 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Fast Moving Consumer Goods Fast Moving Consumer Goods Personal Products Personal Care

Edit Columns
Loading peers table ...

Half Yearly Results

Figures in Rs. Crores

Sep 2019 Mar 2020 Sep 2020 Mar 2021 Sep 2021 Mar 2022 Sep 2022 Mar 2023 Sep 2023 Mar 2024 Sep 2024 Mar 2025
0.26 0.13 0.07 0.12 0.28 0.46 0.82 0.44 0.36 0.85 0.79 1.98
0.20 0.33 0.16 0.36 0.35 0.57 1.01 0.58 0.53 1.00 0.90 2.00
Operating Profit 0.06 -0.20 -0.09 -0.24 -0.07 -0.11 -0.19 -0.14 -0.17 -0.15 -0.11 -0.02
OPM % 23.08% -153.85% -128.57% -200.00% -25.00% -23.91% -23.17% -31.82% -47.22% -17.65% -13.92% -1.01%
0.01 0.26 0.00 0.44 -0.21 0.22 0.24 0.25 0.24 0.24 0.24 0.24
Interest 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.03 0.02 0.01 0.02 0.05
Depreciation 0.05 0.05 0.05 0.05 0.05 0.04 0.04 0.04 0.04 0.04 0.06 0.10
Profit before tax 0.01 0.01 -0.14 0.15 -0.33 0.07 0.01 0.04 0.01 0.04 0.05 0.07
Tax % 0.00% 300.00% 0.00% 0.00% 0.00% -42.86% 0.00% 0.00% 0.00% 0.00% 20.00% 28.57%
0.01 -0.02 -0.13 0.15 -0.33 0.10 0.01 0.03 0.01 0.04 0.03 0.05
EPS in Rs 0.02 -0.04 -0.27 0.31 -0.68 0.21 0.02 0.06 0.02 0.08 0.06 0.10
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
0.03 0.02 0.10 0.14 0.09 0.41 0.39 0.19 0.74 1.26 1.21 2.78
0.03 0.02 0.11 0.08 0.04 0.13 0.53 0.52 0.92 1.60 1.54 2.92
Operating Profit 0.00 0.00 -0.01 0.06 0.05 0.28 -0.14 -0.33 -0.18 -0.34 -0.33 -0.14
OPM % 0.00% 0.00% -10.00% 42.86% 55.56% 68.29% -35.90% -173.68% -24.32% -26.98% -27.27% -5.04%
0.00 0.00 0.01 0.02 0.03 0.11 0.27 0.44 0.01 0.49 0.49 0.48
Interest 0.00 0.00 0.00 0.01 0.01 0.00 0.01 0.00 0.00 0.02 0.03 0.07
Depreciation 0.00 0.00 0.00 0.07 0.07 0.10 0.10 0.10 0.09 0.09 0.08 0.16
Profit before tax 0.00 0.00 0.00 0.00 0.00 0.29 0.02 0.01 -0.26 0.04 0.05 0.11
Tax % 24.14% 150.00% 0.00% -11.54% 0.00% 40.00% 27.27%
0.00 0.00 0.00 0.00 0.00 0.22 -0.01 0.01 -0.23 0.04 0.03 0.08
EPS in Rs 0.00 0.00 0.00 0.00 0.00 0.74 -0.02 0.02 -0.48 0.08 0.06 0.17
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: 64%
5 Years: 48%
3 Years: 55%
TTM: 130%
Compounded Profit Growth
10 Years: %
5 Years: 58%
3 Years: -31%
TTM: 167%
Stock Price CAGR
10 Years: %
5 Years: 50%
3 Years: 35%
1 Year: -45%
Return on Equity
10 Years: 1%
5 Years: 1%
3 Years: 1%
Last Year: 1%

Balance Sheet

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 0.05 0.05 0.05 0.05 0.05 2.96 4.83 4.83 4.83 4.83 4.83 4.83
Reserves 0.88 0.88 0.88 0.88 0.88 1.11 3.73 3.74 3.01 3.04 3.93 5.71
0.59 0.75 0.76 0.87 0.82 0.01 0.00 0.24 0.24 0.84 1.11 0.82
0.00 0.11 0.15 0.10 0.09 0.24 0.23 0.17 0.06 0.24 0.59 1.25
Total Liabilities 1.52 1.79 1.84 1.90 1.84 4.32 8.79 8.98 8.14 8.95 10.46 12.61
1.41 1.59 1.64 1.66 1.59 3.55 3.45 3.36 1.94 1.78 2.43 3.41
CWIP 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.43 0.44 0.00
Investments 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
0.10 0.19 0.19 0.23 0.24 0.76 5.33 5.61 6.19 6.73 7.58 9.19
Total Assets 1.52 1.79 1.84 1.90 1.84 4.32 8.79 8.98 8.14 8.95 10.46 12.61

Cash Flows

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
0.00 0.00 0.00 0.01 0.05 -0.07 -3.42 -0.27 -0.97 -0.97 -0.98 -0.94
0.00 0.00 0.00 -0.01 0.00 -1.96 -0.10 -0.09 0.91 0.13 -0.25 -0.22
0.00 0.00 0.00 0.00 -0.03 2.03 4.18 0.32 -0.13 0.58 1.10 1.34
Net Cash Flow 0.00 0.00 0.00 -0.01 0.02 0.00 0.67 -0.04 -0.18 -0.26 -0.13 0.18

Ratios

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 365.00 365.00 219.00 182.50 243.33 133.54 233.97 384.21 212.09 202.78 337.85 271.78
Inventory Days 2,190.00 4,380.00 438.00 1,460.00 2,737.50 6,448.33 700.80 851.67 344.34 215.16 268.95 151.10
Days Payable 365.00 1,460.00 292.00 730.00 1,095.00 1,460.00 14.60 104.29 20.66 61.47 207.47 176.61
Cash Conversion Cycle 2,190.00 3,285.00 365.00 912.50 1,885.83 5,121.87 920.17 1,131.59 535.77 356.46 399.32 246.27
Working Capital Days 973.33 1,277.50 109.50 286.79 527.22 462.93 4,117.95 9,067.37 2,747.36 1,604.84 1,879.30 950.58
ROCE % 0.00% 0.00% 0.57% 0.56% 9.95% 0.47% 0.12% 2.49% 0.71% 0.86% 1.70%

Shareholding Pattern

Numbers in percentages

Mar 2020Sep 2020Mar 2021Sep 2021Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025May 2025
60.87% 60.87% 60.87% 60.87% 60.87% 60.87% 60.87% 60.87% 60.87% 60.87% 60.87% 51.60%
39.13% 39.13% 39.13% 39.13% 39.13% 39.13% 39.13% 39.13% 39.13% 39.12% 39.13% 48.40%
No. of Shareholders 96174164146138118113118122160142164

Documents

Announcements

Annual reports

DRHP